Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Campath 1H (alemtuzumab) in re...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Campath 1H (alemtuzumab) in renal transplantation: 5-year comparative follow up.
Bibliographic Details
Main Authors:
Watson, C
,
Firth, J
,
Bradley, J
,
Smith, K
,
Jamieson, N
,
Friend, P
,
Hale, G
,
Waldmann, H
,
Bradley, A
,
Calne, S
Format:
Conference item
Published:
2004
Holdings
Description
Similar Items
Staff View
Similar Items
Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five years.
by: Watson, C, et al.
Published: (2005)
Alemtuzumab (CAMPATH-1H) for the treatment of acute rejection in kidney transplant recipients: long-term follow-up.
by: Clatworthy, MR, et al.
Published: (2009)
Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients.
by: Calne, R, et al.
Published: (1998)
Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients.
by: Calne, R, et al.
Published: (1999)
CAMPATH-1 FOLLOWING RENAL-TRANSPLANTATION - A RANDOMIZED TRIAL
by: Friend, P, et al.
Published: (1988)